InvestorsHub Logo
Followers 58
Posts 10039
Boards Moderated 1
Alias Born 09/21/2016

Re: Jonjones325 post# 368811

Tuesday, 08/02/2022 11:02:36 AM

Tuesday, August 02, 2022 11:02:36 AM

Post# of 458346
jonjones325

Now comes 2-73 with an extraordinary amount of detail and safety. Hard to dismiss if it proves to be better.

This is why and how it works. This is why it’s better and this is how we lead the way to understanding CNS diseases. And we’ve shown our platforms effectiveness across diseases and populations.

It’s be amazingly messed up for the FDA to dismiss it and make us to another trial. But I guess we shouldn’t underestimate the power of big pharmas influence.



Excellent...insightful post...THX.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News